Investors

MyEyesAI represents a high-conviction opportunity at the intersection of multimodal AI and critical healthcare infrastructure. As of early 2026, we are positioned as a high-growth venture targeting a massive inefficiency in the $200B+ ophthalmology and emergency care markets.

By automating clinical intelligence, we are not just improving a workflow—we are building the operating system for the future of vision care.

In the current healthcare landscape, a single unnecessary emergency department transfer for an eye complaint can exceed $2,000 per visit. MyEyesAI disrupts this cost structure while simultaneously unlocking new revenue streams for outpatient providers.

• Significant Cost Avoidance: Our “Urgency Scoring” system prevents costly, unnecessary transfers in hospital systems and senior living facilities, saving payers and providers thousands per encounter.
  
• Scalable Revenue Engine: For practices, we enable the capture of automated analysis reimbursement codes (CPT 92229) and increase provider throughput by up to 20% without adding specialist headcount.
  
• Massive Market Tailwinds: With a global aging population and a mounting shortage of ophthalmologists, the demand for “virtual specialist” infrastructure has never been higher.

We are currently raising a $600,000 Seed Round to accelerate our transition from a proven clinical prototype to a national standard in AI-driven triage.

Seed Round Objectives

1. Complete High-Impact Pilots: Finalize ongoing deployments within major hospital systems and PE-owned ophthalmology platforms to solidify our ROI case studies.
   
2. Strengthen Multimodal Workflow: Deepen our EHR integrations (Epic/Cerner) and refine our proprietary multimodal database (imaging + clinical notes + demographics).
   
3. Scale National Traction: Expand our sales and implementation teams to meet the growing demand from independent practices and long-term care facilities across the U.S.

Unlike many “AI-wrapper” startups, MyEyesAI is built on a foundation of clinical excellence. Our models boast 97%+ diagnostic accuracy and have been stress-tested in high-volume, real-world clinical environments.

• Data Moat: Our proprietary multimodal repository provides a significant competitive advantage, allowing for continuous model refinement that generic AI cannot replicate.
  
• Doctor-in-the-Loop Philosophy: Our strategy ensures high physician adoption by supporting—rather than replacing—the specialist, making our platform a “must-have” for risk-averse healthcare institutions.

“Investing in the intersection of multimodal AI and critical healthcare infrastructure with a proven clinical pedigree.”

MyEyesAI is poised to bridge the gap between specialist scarcity and patient need. We invite investors to join us as we democratize expert eye care and build a scalable, high-margin solution for a global healthcare crisis.